C9122 HCPCS Level II code: Mometasone furoate sinus implant, 10 micrograms (sinuva)
CMS terminated C9122: its last date of service was Mar 31, 2021. It stays here for looking up older claims; newer services need a current code.
Official description
C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)
Short description: Mometasone furoate (sinuva)
HCPCS · United States
Medicare details
The indicators CMS publishes with C9122 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See J7402
- Added
- Jul 1, 2020
- Terminated after
- Mar 31, 2021
Where C9122 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9122 still valid?
No. CMS terminated C9122; its last date of service was Mar 31, 2021. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9122?
CMS lists C9122’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9122
All C codesC9096Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgramC9097Inj, faricimab-svoa, 0.1 mgC9098Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures…C9101Injection, oliceridine, 0.1 mgC9113Injection, pantoprazole sodium, per vialC9121Injection, argatroban, per 5 mgC9132Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activityC9133Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.C9134Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.C9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.